Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Back to Intelligence
Mayo’s Riyadh office changes 3 checks for Dubai patients seeking US or London care

Mayo’s Riyadh office changes 3 checks for Dubai patients seeking US or London care

Mayo’s Riyadh office does not treat UAE patients. It changes how Dubai families should compare referrals, records and insurance approvals.

Zavis Intelligence·Healthcare Industry Desk
2 Sept 2026·3 min read

How Zavis verifies this coverage

Editorial standards, source rules, methodology, and review provenance are public.

Mayo Clinic’s Riyadh patient information office gives UAE patients another regional route for arranging US or London care, but it does not replace a licensed hospital visit in Dubai, Abu Dhabi or the northern emirates.

The highest-stakes readers are COOs, medical directors and CFOs at UAE hospitals. A Dubai patient asking about Mayo after the Gulf Business interview should hear one practical answer: the Riyadh office can help with appointments, records, travel, lodging, billing and follow-up, but it is not a clinical facility and does not provide treatment.

What changes for a Dubai patient

For Dubai residents, the first regulator remains the Dubai Health Authority (DHA). A Mayo referral may be useful for rare cancers, transplant assessments, neurology, reconstructive surgery or unresolved diagnoses, but the UAE treating physician still needs to prepare a clear referral note, imaging files, laboratory reports, pathology slides where relevant and medication history.

Mayo lists its international appointment route through International Patient Services. The practical change is geography. A Dubai family can speak to Mayo-linked staff in Riyadh, three hours or less by direct flight in many schedules, before deciding whether to travel to Rochester, Phoenix/Scottsdale, Jacksonville or Mayo Clinic Healthcare in London. London remains the shorter clinical destination for many UAE residents, at roughly seven to eight flight hours from Dubai compared with 15 or more to the US depending on routing.

The cost issue remains unresolved until Mayo reviews the case. Mayo states that costs vary by medical need and insurance coverage. For a Dubai patient, that means the useful number is the written estimate issued after records are reviewed, not a generic online package price. Patients should ask for the estimate in writing, then check pre-authorisation with their insurer before booking flights.

What UAE operators should tell patients

Hospitals in Dubai should treat the Mayo route as a second-opinion and tertiary-referral workflow. It needs document control, consent and a named coordinator. The patient’s UAE medical record should remain the legal record under the local treating facility, with DHA rules applying in Dubai, the Department of Health Abu Dhabi (DOH) applying in Abu Dhabi and Al Ain, and the Ministry of Health and Prevention (MOHAP) applying across the northern emirates.

  • Ask whether the patient wants a second opinion, a full overseas assessment or treatment abroad.
  • Prepare records in English, including radiology DICOM files and recent laboratory values.
  • Get insurer approval before travel when cover may involve Daman, Thiqa, Sukoon or another UAE payer.
  • Record who will manage follow-up in the UAE after the patient returns.

For CFOs, the P&L risk is leakage. A poorly managed overseas referral can shift diagnostics, pharmacy and follow-up away from the UAE provider. A managed referral can retain pre-travel work-up, post-travel rehabilitation and long-term monitoring. For medical directors, the liability question is continuity. The UAE clinician should document why the referral was made, which records were sent and how the foreign opinion will be reconciled with local care.

Abu Dhabi is the comparison point

Abu Dhabi already has a Mayo reference point. In November 2019, Mayo Clinic and SEHA announced a joint venture to operate Sheikh Shakhbout Medical City, described by Mayo as a 741-licensed-bed hospital for serious or rare conditions. In March 2024, Jones Day said Mayo sold its 25% interest in SSMC to SEHA, so UAE patients should check current affiliations directly rather than rely on old brand associations.

The local choice is therefore practical. A Dubai patient with a high-acuity case may compare a DHA-licensed hospital referral, a DOH-regulated Abu Dhabi tertiary service and Mayo’s international route. Northern emirates patients should do the same through MOHAP-licensed providers. The decision should turn on diagnosis, urgency, payer approval, records readiness and the availability of local follow-up, not brand familiarity.

Patients and operators should start by confirming that the UAE provider involved in any referral is licensed. The UAE Government maintains healthcare provider links through the UAE Open Healthcare Directory, which points users to licensed hospitals and providers across Dubai, Abu Dhabi and the northern emirates.

ZI

Zavis Intelligence

Healthcare Industry Desk

Contributing to UAE healthcare industry coverage

Source: Gulf Business

FAQ

What is happening in UAE healthcare industry?

Mayo’s Riyadh office does not treat UAE patients. It changes how Dubai families should compare referrals, records and insurance approvals.